Stock listing

NASDAQ:CCXIU ChemoCentryx Inc. Stock

US listing (NASDAQ) of ChemoCentryx Inc. · home listing NASDAQ:CCXI

Follow ChemoCentryx Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CCXIU

$11.99 USD +1.29 (+12.1%)

Close on Nov 4, 2026

This year +17.4% · daily closes, Dec 17, 2025 – Nov 4, 2026, adjusted for splits
Day range
$11.69 – $11.99 USDNov 4, 2026
Volume
383 sharesNov 4, 2026
Traded on an average day
$48,956 USDMedian day 1,400 shares · 1 day with no trades · last 3 months, Aug 4, 2026 – Nov 4, 2026
ChemoCentryx Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CCXI · Home$11.26 USD+0.57 (+5.3%)4,782,294$11.03$12.17$10.81$10.69Close on Nov 4, 2026
NASDAQ:CCXIU$11.99 USD+1.29 (+12.1%)383$11.69$11.99$11.69$10.70Close on Nov 4, 2026

Daily closes

Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:CCXIU · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$11.99+1.29+12.1%$11.69$11.99$11.69383
$10.70+1.20+12.6%$11.40$11.40$10.70804
$9.50+0.50+5.6%$9.899$9.899$9.50669
$9.00-1.361-13.1%$9.62$9.90$8.991,653
$10.36+0.261+2.6%$10.00$10.36$10.00700
$10.10-0.55-5.2%$10.51$10.51$10.002,700
$10.65+0.24+2.3%$10.65$10.65$10.65400
$10.41-0.44-4.1%$10.32$10.50$10.324,700
$10.85+0.25+2.4%$10.85$10.85$10.85200
$10.60-0.01-0.1%$10.75$10.85$10.5014,800
$10.61-0.39-3.5%$10.54$10.61$10.541,100
$11.00+0.42+4.0%$10.80$11.00$10.611,800
$10.58-0.52-4.7%$10.58$10.58$10.581,400
$11.10-0.90-7.5%$11.60$11.60$10.509,400
$12.00+0.80+7.1%$11.20$12.00$11.054,400
$11.20-0.27-2.4%$11.11$11.20$11.045,700
$11.47+0.445+4.0%$11.29$11.58$11.215,500
$11.03-0.675-5.8%$11.21$11.21$10.451,600
$11.70-0.05-0.4%$11.70$11.70$11.70200
$11.75-0.25-2.1%$11.92$11.92$11.751,000
$12.000.000.0%$12.00$12.00$12.000
$12.00-0.50-4.0%$12.00$12.00$12.001,300
$12.500.000.0%$12.50$12.50$12.50300
$12.500.000.0%$12.50$12.50$12.50100
$12.50+0.25+2.0%$12.50$12.50$12.50200
$12.25-0.45-3.5%$12.25$12.30$12.253,600
$12.70+0.03+0.2%$12.67$12.70$12.502,400
$12.67-0.23-1.8%$12.67$12.67$12.67300
$12.90+0.24+1.9%$12.68$13.00$12.6736,400
$12.66-0.59-4.5%$13.20$13.20$12.5211,600
$13.25-0.74-5.3%$13.25$13.25$13.251,100
$13.99+0.01+0.1%$14.00$14.49$13.991,200
$13.98+1.245+9.8%$13.21$13.98$13.21600
$12.74-0.765-5.7%$13.00$13.79$12.504,900
$13.50+1.00+8.0%$13.50$13.50$13.50200
$12.50-1.01-7.5%$13.39$13.69$12.502,900
$13.51+1.01+8.1%$12.96$13.51$12.283,100
$12.50-1.29-9.4%$12.90$14.40$12.501,400
$13.79+0.28+2.1%$14.37$14.37$12.6120,900
$13.51-0.89-6.2%$13.51$13.90$13.51700
$14.40-0.29-2.0%$14.40$14.40$14.40700
$14.69-0.78-5.0%$14.00$14.69$13.908,500
$15.47+0.47+3.1%$14.20$15.47$14.201,300
$15.00+0.50+3.4%$14.00$15.00$14.00800
$14.50+0.50+3.6%$14.50$14.50$14.50500
$14.00-0.10-0.7%$14.00$14.00$13.541,700
$14.10-0.40-2.8%$14.45$14.45$14.10700
$14.50-1.25-7.9%$14.50$14.50$14.50500
$15.75-0.50-3.1%$16.34$16.34$15.75900
$16.25+1.00+6.6%$14.71$16.25$14.711,400
$15.25+0.28+1.9%$15.50$15.50$15.251,304
$14.97-0.045-0.3%$14.58$15.30$14.581,937
$15.02-0.085-0.6%$15.59$15.59$15.022,100
$15.10-0.90-5.6%$15.00$15.45$15.004,200
$16.00-0.53-3.2%$16.13$17.50$15.039,200
$16.53-1.38-7.7%$17.48$18.09$16.513,200
$17.91+0.935+5.5%$18.47$19.40$17.8619,900
$16.98-0.095-0.6%$17.50$17.50$16.961,400
$17.07-0.07-0.4%$17.63$17.63$16.302,400
$17.14-0.26-1.5%$17.14$17.14$17.14500
$17.40-0.10-0.6%$18.00$18.20$17.401,682
$17.50+0.357+2.1%$17.14$18.00$17.143,801
$17.14+0.453+2.7%$17.14$17.14$17.14400
$16.69+0.09+0.5%$16.50$16.71$16.502,900
$16.60+0.20+1.2%$15.97$16.78$15.977,200
$16.40+0.30+1.9%$16.70$17.91$15.034,600
Ticker
NASDAQ:CCXIU
Asset type
Fund
Sector
Financials
Industry
Shell companies & SPACs
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All ChemoCentryx Inc. news

ChemoCentryx Inc. on 6ix

Sector
Financials
Industry
Shell companies & SPACs
News releases
5 in the last 12 months · 46 in all · newest Nov 2, 2026 · oldest 2019
Calls
5 calls with a replay · 5 with a transcript · latest May 5, 2022
Decks
1 deck · latest Jan 16, 2020

Where ChemoCentryx Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CCXI · Home listingNASDAQUnited StatesUSD
BOATS:CCXIBOATSUnited StatesUSD
NASDAQ:CCXIU · This pageNASDAQUnited StatesUSD

Valuation

Statements: 4 quarters to Jun 30, 2026 · price Nov 4, 2026

Enterprise value
$470.5M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
1.8×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.21

Shell companies & SPACs: the 10 companies nearest in size, of 285 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ChemoCentryx Inc. · NASDAQ:CCXIUS$471.8MUS$470.5Mn/an/an/a1.8×n/a0.0×1.21
EQV Ventures Acquisition Corp. II · NYSE:EVACUS$489.7MUS$488.8M29.7×n/an/an/an/an/a0.00
Bain Capital GSS Investment Corp. · NYSE:BCSSUS$481.2MUS$481.2M29.2×n/an/an/an/an/a0.04
B&R Technology Merger Corp. · NASDAQ:BRTMUS$479.2MUS$478.3Mn/an/an/an/an/an/an/a
Cantor Equity Partners IV, Inc. · NASDAQ:CEPFUS$474.1MUS$474.1M28.5×n/an/an/an/an/a0.02
General Catalyst Global Resilience Merger Corp. · NASDAQ:GCGRUS$460.0MUS$459.5Mn/an/an/an/an/an/an/a
Churchill Capital Corp XII · NASDAQ:CXIIUS$430.7MUS$429.3M74.9×n/an/an/an/an/an/a
K&F Growth Acquisition Corp. II · NASDAQ:KFIIUS$416.5MUS$416.5M42.0×n/an/an/an/an/a-0.03
Ares Acquisition Corp. III · NYSE:AACUS$391.1MUS$389.1Mn/an/an/an/an/an/an/a
Keystone Acquisition Corp. · NASDAQ:KEYYUS$381.0MUS$380.1Mn/an/an/an/an/an/an/a
Gores Holdings X, Inc. · NASDAQ:GTENUS$377.1MUS$377.0M36.6×n/an/an/an/an/a0.02
Median of the othersUS$445.3MUS$444.4M33.2×0.02

Events

CallWhenStatus
ChemoCentryx (NASDAQ:CCXI) Q1 2022 Earnings CallThu, May 05, 2022 · 5:00 PM ETReplay
ChemoCentryx (NASDAQ:CCXI) Q4 2021 Earnings CallTue, Mar 01, 2022 · 5:00 PM ETReplay
ChemoCentryx (NASDAQ:CCXI) Q3 2021 Earnings CallTue, Nov 09, 2021 · 5:00 PM ETReplay
ChemoCentryx (NASDAQ:CCXI) Q2 2021 Earnings CallMon, Aug 09, 2021 · 5:00 PM ETReplay
ChemoCentryx (NASDAQ:CCXI) Q3 2020 Earnings CallMon, Nov 09, 2020 · 5:00 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2020)Investor deck38 slidesJan 16, 2020

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025
Operating income-167.7K
Income before tax382.1K
Net income382.1K
Earnings per share, basic0.01

Balance sheet

LineFY2025
Cash and equivalents736.2K
Current assets1.06M
Total assets415.9M
Current liabilities130.7K
Total liabilities16.1M
Shareholders' equity399.8M
Shares outstanding55.7M

Cash flow

LineFY2025
Cash from operations-632.8K
Capital spending-4
Free cash flow-632.8K
Cash from investing-414.0M
Cash from financing415.4M
Change in cash736.2K

Open Financials

Cap table

Built by 6ix from ChemoCentryx Inc.’s releases

Common shares
41,900,000
Fully diluted
41,900,000

Fully diluted

LineShares
Common shares41,900,000

Share count over time

CountShares
Nov 22, 202641,900,000

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Value Aligned Research Advisors, LLC1.53MUS$17.7MSep 30, 2026
Empyrean Capital Partners, LP1.5MUS$17.4MSep 30, 2026
BlueCrest Capital Management Ltd1.3MUS$15.1MSep 30, 2026
D. E. Shaw & Co., Inc.1.23MUS$14.3MSep 30, 2026
Polar Asset Management Partners Inc.1.2MUS$14MSep 30, 2026
Shay Capital LLC762KUS$8.86MSep 30, 2026
Creek Drive Management Group LLC707KUS$8.22MSep 30, 2026
ExodusPoint Capital Management, LP700KUS$8.13MSep 30, 2026
Magnetar Financial LLC665KUS$7.72MSep 30, 2026
Healthcare Of Ontario Pension Plan Trust Fund600KUS$6.97MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Citadel470KUS$5.46MSep 30, 2026
T3 Companies, LLC465KUS$5.41MSep 30, 2026
Moore Capital Management, LP435KUS$5.05MSep 30, 2026
DLD Asset Management, LP394KUS$4.58MSep 30, 2026
Goldman Sachs380KUS$4.41MSep 30, 2026
Jane Street371KUS$4.31MSep 30, 2026
Alberta Investment Management Corp364KUS$4.23MSep 30, 2026
Sculptor Capital LP332KUS$3.86MSep 30, 2026
Peak6 LLC332KUS$3.85MSep 30, 2026
ADAR1 Capital Management, LLC273KUS$3.18MSep 30, 2026
IMC-Chicago, LLC205KUS$2.38MSep 30, 2026
Susquehanna190KUS$2.21MSep 30, 2026
K2 Principal Fund, L.P.182KUS$2.12MSep 30, 2026
Exchange Traded Concepts, LLC165KUS$1.92MSep 30, 2026
Hrt Financial LP165KUS$1.98MSep 30, 2026
FNY Investment Advisers, LLC164KUS$1.91MSep 30, 2026
Scoggin Management LP125KUS$1.45MSep 30, 2026
LPL Financial LLC124KUS$1.44MSep 30, 2026
Apollon Wealth Management, LLC113KUS$1.31MSep 30, 2026
Brant Point Investment Management LLC104KUS$1.21MSep 30, 2026
Wexford Capital LP100KUS$1.16MSep 30, 2026
Fort Baker Capital Management LP100KUS$1.16MSep 30, 2026
Sowell Financial Services LLC97,017US$1.13MSep 30, 2026
Polen Capital Management LLC90,618US$1.05MSep 30, 2026
LMR Partners LLP85,794US$997KSep 30, 2026
Linden Advisors LP82,230US$956KSep 30, 2026
Artemis Wealth Advisors, LLC80,000US$930KSep 30, 2026
Verition Fund Management LLC75,000US$872KSep 30, 2026
Tenor Capital Management Company, L.P.72,458US$842KSep 30, 2026
Sphera Management Technology Funds Ltd70,000US$813KSep 30, 2026
Schonfeld Strategic Advisors LLC69,368US$806KSep 30, 2026
Marex Group Ltd66,600US$774KSep 30, 2026
UBS57,806US$672KSep 30, 2026
Simplex Trading, LLC54,916US$638KSep 30, 2026
Universal- Beteiligungs- und Servicegesellschaft mbH50,000US$581KSep 30, 2026
Periscope Capital Inc.50,000US$581KSep 30, 2026
OMERS ADMINISTRATION Corp50,000US$581KSep 30, 2026
Murchinson Ltd.50,000US$581KSep 30, 2026
Capital Asset Advisory Services LLC48,256US$523KSep 30, 2026
NLB Skladi, upravljanje premozenja, d.o.o.46,708US$543KSep 30, 2026

This page holds 50 of 91 holders. Open Shareholders

Funds

HolderSharesValueAs of
Comstock Capital Value Fund2,000US$34,900Jun 30, 2026
Fidelity Nasdaq Composite Index Fund1,186US$12,168May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Churchill Sponsor XI LLC25.67%14.3MDec 18, 2025Schedule 13D
Huang Rich5.51%2.45MOct 28, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Klein
Other companies: Churchill Capital Corp. XIII (See Remarks, Director · Since at least Jul 30, 2026); Churchill Capital Corp XII (See Remarks, Director · Since at least Apr 27, 2026); Agility Robotics, Inc. (See Remarks, Director · Since at least Dec 16, 2025); Infleqtion, Inc. (See Remarks, Director · Since at least May 13, 2025); Oklo Inc. (Board Member · Since at least Jul 7, 2021); Claritev Corporation (Director · Since at least Feb 13, 2020); Skillsoft Corp. (Director · Since at least Jun 26, 2019); Churchill Capital Corp VII (See Remarks, Director · Feb 11, 2021 – Feb 11, 2021 · Past); Churchill Capital VI Corp (See Remarks, Director · Feb 11, 2021 – Feb 11, 2021 · Past); Churchill Capital V Corp (See Remarks, Director · Dec 15, 2020 – Dec 15, 2020 · Past); Lucid Group, Inc. (See Remarks, Director · Jul 29, 2020 – Jul 29, 2020 · Past); Gordon Pointe Acquisition Corp (Director · Jul 1, 2020 – Jul 22, 2020 · Past); IHS Holding Limited (Director · Dec 1, 2008 – Apr 10, 2013 · Past); Citigroup, Inc. (Co-CEO Citi Markets & Banking · Feb 1, 2007 – Jan 22, 2008 · Past)
See Remarks, Director · Since at least Nov 2, 2026
David E. Wheadon
Other companies: Indivior Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Supernus Pharmaceuticals, Inc. (Director · Since at least Jan 1, 2026); Vaxart, Inc. (Director · Since at least Aug 4, 2022); Sotera Health Company (Director · Since at least May 27, 2022); Karuna Therapeutics Inc (Director · Jun 15, 2022 – Mar 18, 2024 · Past)
Director · May 26, 2022 – Oct 20, 2022 · Past
Henry A McKinnell
Other companies: Federal Street Acquisition Corp (Director · Jul 13, 2017 – Jan 4, 2019 · Past); Optimer Pharmaceuticals Inc (CEO and Chairman of the Board, Director · Jan 10, 2011 – Oct 24, 2013 · Past); Angiotech Pharmaceuticals Inc (Director · May 12, 2008 – Dec 10, 2009 · Past); Moody's Corporation (Director · Feb 8, 2006 – Mar 18, 2021 · Past); Exxon Mobil Corporation (Director · Dec 30, 2005 – May 30, 2007 · Past); Pfizer, Inc. (Director · Dec 30, 2005 – Feb 28, 2007 · Past)
Director · Oct 17, 2016 – May 20, 2022 · Past
James L. Tyree
Other companies: Genelux Corporation (Lead Independent Director · Since at least Jan 25, 2023); Assertio Holdings, Inc. (Director · May 19, 2020 – Mar 14, 2024 · Past); Depomed Inc (Director · Oct 17, 2016 – May 8, 2018 · Past); Innoviva, Inc. (Director · Jun 2, 2014 – Apr 20, 2017 · Past); Abbott Laboratories (Executive Vice President · Feb 14, 2006 – Feb 27, 2009 · Past)
Director · Jun 5, 2012 – Oct 20, 2022 · Past
Rishi Gupta
Other companies: Turnstone Biologics Corp. (Director · Since at least Jul 20, 2023); Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Feb 23, 2023); Verona Pharma plc (Director · Jan 1, 2021 – May 11, 2023 · Past); Dimension Therapeutics (Director · Oct 21, 2015 – May 19, 2016 · Past); Sientra Inc (Director · Oct 28, 2014 – Oct 28, 2014 · Past)
Director · Feb 8, 2012 – Jun 22, 2012 · Past
William C. Fairey
Other companies: Ascendis Pharma A/S (Director · Since at least Mar 18, 2026); KalVista Pharmaceuticals, Inc. (Director · Since at least Apr 18, 2024); Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Mirum Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2021); MyoKardia Inc (EVP, Chief Commercial Officer · Jan 28, 2019 – Nov 17, 2020 · Past)
Chief Operating Officer · Jan 3, 2018 – Jan 3, 2018 · Past
Anne-Marie Duliege
Other companies: Rigel Pharmaceuticals, Inc. (EVP & Chief Medical Officer · Mar 7, 2016 – Mar 20, 2019 · Past); Affymax Inc (Chief Medical Officer · Jan 1, 2008 – Jan 30, 2013 · Past)
EVP, Chief of Strategic Dev. · Mar 25, 2014 – Nov 18, 2014 · Past
Edward Penhoet
Other companies: Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Scynexis, Inc. (Director · May 2, 2014 – Jun 4, 2015 · Past)
Director · Feb 8, 2012 – May 23, 2013 · Past
Joseph M Feczko
Other companies: Keryx Biopharmaceuticals Inc (Director · Jul 16, 2010 – Jun 17, 2015 · Past); Pfizer, Inc. (Senior Vice President · Dec 30, 2005 – Mar 13, 2009 · Past)
Director · Apr 25, 2012 – Oct 20, 2022 · Past
Jennifer Lyn Herron
Other companies: Ariad Pharmaceuticals Inc (Exec V.P. Chief Comm'l Officer · May 31, 2016 – Feb 16, 2017 · Past)
Director · Jun 28, 2022 – Oct 20, 2022 · Past
All 20 people
PersonSeat
Juan Jaen
Other companies: Arcus Biosciences, Inc. (President · Since at least Mar 14, 2018)
SVP, Drug Discovery & CSO · Feb 8, 2012 – Jul 23, 2013 · Past
Roger C Lucas
Other companies: Bio-Techne Corp (Director · Feb 1, 2006 – Oct 10, 2017 · Past)
Director · Feb 8, 2012 – Mar 5, 2019 · Past
Thomas J Schall
Other companies: Immuneering Corporation (Director · Since at least Mar 11, 2024)
President and CEO, Director · Feb 8, 2012 – Oct 20, 2022 · Past
Israel CharoSVP, Research · Sep 17, 2014 – Sep 18, 2014 · Past
Markus J CappelChief Bus. Officer & Treasurer · Feb 8, 2012 – Oct 20, 2022 · Past
Pui San KwanPrincipal Acctg Officer · Mar 5, 2018 – Feb 25, 2021 · Past
Rajinder SinghSVP, Research · Apr 15, 2019 – Apr 15, 2019 · Past
Susan M KanayaSee Remarks, Director · Feb 8, 2012 – Oct 20, 2022 · Past
Tausif ButtEVP, Chief Operating Officer · Feb 23, 2021 – Oct 20, 2022 · Past
Thomas A EdwardsDirector · Jul 28, 2015 – Oct 20, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about ChemoCentryx Inc.